XML 60 R48.htm IDEA: XBRL DOCUMENT v3.21.2
GOODWILL AND INTANGIBLE ASSETS (Details) - USD ($)
 1 Months Ended 3 Months Ended 9 Months Ended
Apr. 30, 2019
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Goodwill            
Change in carrying value of goodwill during period   $ 0   $ 0    
Goodwill recorded in connection with the acquisition   99,547,000   99,547,000   $ 99,547,000
Amortization of acquired intangible assets   1,967,000 $ 1,967,000 5,900,000 $ 5,900,000  
Amortization expense, remainder of fiscal year   2,000,000   2,000,000    
Amortization expense, first period   7,900,000   7,900,000    
Amortization expense, second period   2,200,000   2,200,000    
Myoscience Acquisition            
Goodwill            
Goodwill acquired during period $ 37,500,000          
Upon first commercial sale in a major EU country (United Kingdom, France, Germany, Italy and Spain) | Skye Pharma Holding Inc.            
Goodwill            
Milestone payments for EXPAREL agreed in connection with acquisition   4,000,000   4,000,000    
When annual net sales collected reach $500.0 million | Skye Pharma Holding Inc.            
Goodwill            
Milestone payments for EXPAREL agreed in connection with acquisition   32,000,000   32,000,000    
Annual net sales threshold   $ 500,000,000   $ 500,000,000